HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 357 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,753 | -60.5% | 312 | -72.4% | 0.01% | -57.1% |
| Q3 2022 | $45,000 | -6.2% | 1,132 | +3.6% | 0.02% | -4.5% |
| Q2 2022 | $48,000 | +29.7% | 1,093 | +16.6% | 0.02% | +57.1% |
| Q1 2022 | $37,000 | +236.4% | 937 | +250.9% | 0.01% | +250.0% |
| Q4 2021 | $11,000 | +1000.0% | 267 | +1171.4% | 0.00% | – |
| Q3 2021 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |